Showing results (91-100 of 219) with videos related to
Sort By:
Pageof 22
Obesity (Silver Spring, Md.)|August 6, 2011
Role of thrombospondin-2 in murine adipose tissue angiogenesis and developmentMatthias Van Hul, Liesbeth Frederix, H Roger LijnenAnnals of Human Genetics|July 1, 1979
A two-locus model for the inheritance of a familial diseaseA Merry, J H Roger, R N CurnowPharmaceutical Statistics|July 16, 2024
Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple ImputationSuzie Cro, James H Roger, James R CarpenterBiochimica Et Biophysica Acta|January 16, 2003
Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territoriesGabor Voros, Erik Maquoi, Désiré Collen, et al.Thrombosis and Haemostasis|March 18, 2006
Impairment of adipose tissue development by hypoxia is not mediated by plasminogen activator inhibitor-1Fabrizio Semeraro, Gabor Voros, Désiré Collen, et al.Pharmaceutical Statistics|March 29, 2007
Practical usage of O'Brien's OLS and GLS statistics in clinical trialsNigel S Dallow, Sergei L Leonov, James H RogerJournal of Economic Entomology|June 22, 2013
Evaluation of pest vulnerability of 'Benning' soybean value added and insect resistant near isogenic linesMichelle Samuel-Foo, John N All, H Roger BoermaStudies in Health Technology and Informatics|September 15, 2005
Purposes of health identification cards in belgiumFrancis H Roger France, Etienne De Clercq, Marc BangelsThe Journal of Heredity|May 2, 2012
SSR-marker analysis of the intracultivar phenotypic variation discovered within 3 soybean cultivarsJennifer L Yates, H Roger Boerma, Vasilia A FasoulaJournal of Biopharmaceutical Statistics|October 22, 2013
Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputationJames R Carpenter, James H Roger, Michael G KenwardPageof 22